María-Luisa Laorden

María-Luisa Laorden

Auto-generated profile, based on publicly available information

María-Luisa Laorden

Department of Pharmacology, School of Medicine, Campus Mare Nostrum, University of Murcia, Institute for Bio-Health Research of Murcia (IMIB), Murcia, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

6 October 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LCLorena Cuenca-Bermejo
Lorena Cuenca-Bermejo
PAPilar Almela
Pilar Almela
PGPablo Gallo-Soljancic
Pablo Gallo-Soljancic
JYJOSE ENRIQUE YUSTE
JOSE ENRIQUE YUSTE
VPVicente de Pablos
Vicente de Pablos
MHMaría Trinidad Herrero
María Trinidad Herrero
The impact of age-associated disorders is increasing as the life expectancy of the population increments. Cardiovascular diseases and neurodegenerative disorders, such as Parkinson’s disease, have the highest social and economic burden and increasing evidence show interrelations between them. Particularly, dysfunction of the cardiovascular nervous system is part of the dysautonomic symptoms of Parkinson’s disease, although more studies are needed to elucidate the role of cardiac function on it. We analyzed the dopaminergic system in the nigrostriatal pathway of Parkinsonian and dyskinetic monkeys and the expression of some key proteins in the metabolism and synthesis of catecholamines in the heart: total and phosphorylated (phospho) tyrosine hydroxylase (TH), and membrane (MB) and soluble (S) isoforms of catechol-O-methyl transferase (COMT). The dopaminergic system was significantly depleted in all MPTP-intoxicated monkeys. MPTP- and MPTP + L-DOPA-treated animals also showed a decrease in total TH expression in both right (RV) and left ventricle (LV). We found a significant increase of phospho-TH in both groups (MPTP and MPTP + L-DOPA) in the LV, while this increase was only observed in MPTP-treated monkeys in the RV. MB-COMT analysis showed a very significant increase of this isoform in the LV of MPTP- and MPTP + L-DOPA-treated animals, with no significant differences in S-COMT levels. These data suggest that MB-COMT is the main isoform implicated in the cardiac noradrenergic changes observed after MPTP treatment, suggesting an increase in noradrenaline (NA) metabolism. Moreover, the increase of TH activity indicates that cardiac noradrenergic neurons still respond despite MPTP treatment.